- Safety & Recalls
- Regulatory Updates
- Drug Coverage
- COPD
- Cardiovascular
- Obstetrics-Gynecology & Women's Health
- Ophthalmology
- Clinical Pharmacology
- Pediatrics
- Urology
- Pharmacy
- Idiopathic Pulmonary Fibrosis
- Diabetes and Endocrinology
- Allergy, Immunology, and ENT
- Musculoskeletal/Rheumatology
- Respiratory
- Psychiatry and Behavioral Health
- Dermatology
- Oncology
Analgesics linked to hearing loss in women
Women who regularly took the analgesics ibuprofen or acetaminophen 2 more days per week had an increased risk of hearing loss, according to a recent study published in a recent issue of the American Journal of Epidemiology.
Women who regularly took the analgesics ibuprofen or acetaminophen 2 or more days per week had an increased risk of hearing loss, according to a study published in a recent issue of the American Journal of Epidemiology.
This is the first large prospective study of the relation between regular use of these analgesics and the risk of hearing loss in women.
Researchers at Brigham and Women’s Hospital (BWH) in Boston studied more than 60,000 women who were participants in the Nurses’ Health Study II. The participants were followed for 14 years in order to prospectively examine whether analgesic use is a risk factor for hearing loss in women. During follow-up, more than 10,000 women developed hearing loss.
“It appeared that the more often a woman took either of these medications, the higher her risk,” lead study author Sharon Curhan, MD, MSc, department of medicine, Channing Division of Network Medicine, BWH, told Formulary.
“We found that compared with women who used ibuprofen less than 1 day per week, the increased risk of developing hearing loss ranged from 13% for those who used ibuprofen 2 to 3 days per week to 24% for women who used it 6 or more days per week,” Dr Curhan said.
Compared with women who used acetaminophen less than 1 day per week, women who used acetaminophen 2 to 3 days per week had an 11% increased risk for hearing loss, while women taking the medicine 4 to 5 days per week had a 21% increased risk.
There was no association between aspirin use and hearing loss.
“Even though these analgesics are widely available. . .without a prescription, these are still medications and there are potential side effects,” Dr Curhan said. “If individuals find a need to take these types of medications regularly, they should consult with their healthcare professional in order to discuss the risks and benefits and to explore possible alternatives.”
This research was supported by the National Institutes of Health and by Vanderbilt University School of Medicine.
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.
